Both pGHRH-R and its variants are GPCRs and appear to mediate the effects of GHRH in tumours, where it acts as an autocrine/paracrine growth factor in several types of human cancers and, similarly, IGF-I acts as a potent mitogen for tumour cell growth and proliferation [18]. Here, IGF1 is linked to neoplasm.